Biden’s FDA Needs Course Corrections to Increase Covid-19 Testing

The FDA under President Joe Biden has the opportunity to improve the availability of Covid-19
testing. Hyman, Phelps & McNamara P.C. attorneys say the FDA can start by eliminating needless
hurdles in the regulatory approval process, providing greater clarity, and applying criteria
consistently.